> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Approves Edwards Aortic Valved Conduit
- URL: https://www.fdaweb.com/fda-approves-edwards-aortic-valved-conduit/
- Published: 2020-07-15T12:00:00.000Z
- Updated: 2026-09-14T16:21:15.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5147204

FDA has approved an Edwards Lifesciences PMA for the Konect Resilia aortic valved conduit, a ready-to-implant device for bio-Bentall procedures, a complex surgery that involves replacement of a patient’s aortic valve, aortic root and the ascending aorta. The device features the company’s Resilia tissue, which uses an “integrity-preservation technology” that allows devices to be stored under dry packaging conditions, the company says. About 30% of Bentall procedures are performed in an emergency setting, such as when patients with valve disease experience a combination of issues with the aorta, including aneurysm, regurgitation, or separation, Edwards says.